Stock Fundamentals

Company Information

Company Name
Immunovant Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45258J1025
CIK: 0001764013
CUSIP: 45258J201
Currency: USD
Full Time Employees: 315
Phone: 917 410 3120
Fiscal Year End: March
IPO Date: Jun 21, 2019
Description:

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

Address:

1000 Park Forty Plaza, Durham, NC, United States, 27713

Directors & Officers

Name Title Year Born
Dr. Frank M. Torti M.B.A., M.D. Executive Chairperson of the Board 1979
Dr. Eric Venker M.D., Pharm.D. CEO & Director 1987
Ms. Melanie Gloria B.S.N. Chief Operating Officer 1978
Mr. Christopher A. Van Tuyl Esq., J.D. Chief Legal Officer & Corporate Secretary 1976
Mr. Tiago M. Girao CPA Chief Financial Officer 1979
Dr. Jay S. Stout M.S., Ph.D. Chief Technology Officer 1964
Ms. Christine Blodgett Senior Vice President of Human Resources NA
Mr. Andy Deig M.B.A. Senior Vice President of Strategic Finance NA
Ms. Julie Kirschling Senior Vice President of Program & Alliance Management NA
Ms. Becky Merlina Senior VP & Global Head of Quality NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 23, 2026 Tiago Girao N/A Sale 25.76K $29.62 $763.01K
Apr 23, 2026 Jay S Stout N/A Sale 2.75K $29.62 $81.57K
Apr 08, 2026 Jay S Stout N/A Sale 10.13K $24.83 $251.58K
Apr 08, 2026 Melanie Gloria N/A Sale 8.72K $24.83 $216.57K
Apr 08, 2026 Tuyl Christopher Van N/A Sale 5.17K $24.83 $128.25K
Apr 02, 2026 Eric Venker N/A Sale 14.23K $24.10 $342.92K
Mar 18, 2026 Tuyl Christopher Van N/A Sale 2.88K $24.97 $71.84K
Jan 21, 2026 Jay S Stout N/A Sale 1.98K $26.03 $51.46K
Jan 07, 2026 Jay S Stout N/A Sale 1.20K $26.53 $31.92K
Dec 18, 2025 Tuyl Christopher Van N/A Sale 10.81K $26.91 $290.98K
Dec 01, 2025 Andrew J Fromkin N/A Sale 22.25K $23.25 $517.29K
Dec 01, 2025 Douglas J Hughes N/A Sale 15.00K $23.24 $348.60K
Nov 20, 2025 Melanie Gloria N/A Sale 12.63K $23.62 $298.23K
Oct 22, 2025 Jay S Stout N/A Sale 2.52K $19.03 $47.96K
Oct 22, 2025 Michael Geffner N/A Sale 2.60K $19.03 $49.38K
Oct 08, 2025 Jay S Stout N/A Sale 1.59K $16.30 $25.84K
Oct 08, 2025 Michael Geffner N/A Sale 1.27K $16.30 $20.73K
Jul 23, 2025 Jay S Stout N/A Sale 2.81K $18.15 $50.91K
Jul 23, 2025 Michael Geffner N/A Sale 2.39K $18.15 $43.29K
Jul 09, 2025 Jay S Stout N/A Sale 1.52K $17.24 $26.19K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 16.95M Mar 31, 2026 8.31% $0.02 -0.25%
Deep Track Capital, LP 11.53M Mar 31, 2026 5.65% $4.68 0.00%
Vanguard Group Inc 7.78M Dec 31, 2025 3.81% $0.00 13.95%
BlackRock Inc 6.57M Mar 31, 2026 3.22% $0.00 8.52%
Baker Bros Advisors LP 5.46M Mar 31, 2026 2.68% $0.78 0.00%
State Street Corp 4.54M Mar 31, 2026 2.23% $0.00 19.83%
TCG Crossover Management, LLC 4.46M Mar 31, 2026 2.19% $3.17 168.40%
Morgan Stanley - Brokerage Accounts 3.88M Mar 31, 2026 1.90% $0.01 -20.00%
T. Rowe Price Investment Management,Inc. 3.61M Mar 31, 2026 1.77% $0.06 -35.87%
Armistice Capital, LLC 3.56M Mar 31, 2026 1.75% $1.57 -37.97%
Two Seas Capital LP 3.20M Mar 31, 2026 1.57% $1.11 11.68%
Jennison Associates LLC 3.20M Mar 31, 2026 1.57% $0.05 356.37%
RTW INVESTMENTS, LLC 3.18M Mar 31, 2026 1.56% $0.79 0.00%
ADAR1 Capital Management LLC 2.68M Mar 31, 2026 1.31% $3.92 7.98%
Alpine Partners VI, LLC 2.64M Mar 31, 2026 1.29% $9.81 0.39%
Geode Capital Management, LLC 2.09M Mar 31, 2026 1.03% $0.00 12.63%
Woodline Partners LP 1.98M Mar 31, 2026 0.97% $0.19 0.00%
The Goldman Sachs Group Inc 1.79M Mar 31, 2026 0.88% $0.01 37.74%
Perceptive Advisors LLC 1.60M Mar 31, 2026 0.78% $0.78 -19.93%
Farallon Capital Management, L.L.C. 1.55M Mar 31, 2026 0.76% $0.22 12,783.33%

Shares Statistics

Shares Outstanding: 205.31M
Shares Float: 78.84M
% Insiders: 5,674.90%
% Institutions: 5,473.20%
Short % Float: 22.44%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Growth Compy Commingled Pl S 6.93M 3.40% ▲ 1.34% Mar 31, 2026
2 Fidelity Growth Company Fund 5.10M 2.50% ▲ 1.32% Mar 31, 2026
3 State Street® SPDR® S&P® Biotech ETF 2.87M 1.41% ▼ 0.71% Apr 30, 2026
4 Vanguard Total Stock Mkt Idx Inv 2.61M 1.28% ▲ 0.43% Apr 30, 2026
5 iShares Russell 2000 ETF 1.91M 0.94% ▲ 0.85% Apr 30, 2026
6 Vanguard Small Cap Index 1.87M 0.92% ▼ 0.42% Apr 30, 2026
7 Fidelity Growth Company K6 1.41M 0.69% ▲ 0.70% Mar 31, 2026
8 T. Rowe Price US Small-Cap Core Equity 1.32M 0.65% ▼ 24.36% Mar 31, 2026
9 T. Rowe Price Small-Cap Stock 1.32M 0.65% ▼ 22.77% Mar 31, 2026
10 Fidelity Series Growth Company 1.26M 0.62% ▲ 5.17% Mar 31, 2026

Valuation Metrics

Enterprise Value: $5.84B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $6.35B
EBITDA: $-532.49M
Book Value: $4.85
Earnings/Share: $-2.77
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -38.43%
ROE (TTM): -64.82%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2026-03-31 9.09x 0.00x 0.11x N/A 0.00x
2025-03-31 11.16x 0.00x 0.09x N/A 0.00x
2024-03-31 13.70x 0.00x 0.07x -5.42x 0.00x
2023-03-31 9.34x 0.00x 0.11x -16.69x -0.01x
2022-03-31 11.52x 0.00x 0.09x -238.22x -0.01x
2021-03-31 21.79x 0.00x 0.05x N/A -0.01x
2020-03-31 7.12x 0.03x 0.14x -95.48x -0.05x
2019-03-31 0.85x 12.22x 0.94x N/A -10.56x
2018-03-31 0.07x 0.00x 14.23x N/A N/A

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IMVT.US!